Community methicillin resistant Staphylococcus aureus infection at the Fundacion Hospital de la Misericordia betwwen 2011 and 2013
PDF (Español (España))

Keywords

Staphylococcus aureus meticilinoresistente
Infecciones adquiridas en comunidad
Factor de riesgo
Resistencia a la meticilina
Epidemiologia
infección Methicillin resistant Staphylococcus aureus
Community-acquired infection
Methicillin resistance
Epidemiology
And infection

How to Cite

Camacho Moreno, G. ., Cortés C., L. F. ., & Pabón R., S. . (2014). Community methicillin resistant Staphylococcus aureus infection at the Fundacion Hospital de la Misericordia betwwen 2011 and 2013. Revista Médica Sanitas, 17(3), 110-118. Retrieved from //revistas.unisanitas.edu.co/index.php/rms/article/view/343

Abstract

Introduction: methicillin resistant Staphylococcus aureus infection (MRSA) correlates with a high virulence and causes skin and soft tissue infections and necrotizing pneumonia in healthy adults and children. The first community acquired MRSA reports appeared in the 90’s. The prevalence of the infection among the pediatric population is variable, depending on the geographical location and the health institution, reaching values of up to 48%. Objective: to determine the risk factors associated with invasive community acquired methicillin resistant Staphylococcus aureus infection in pediatric patients hospitalized at the Hospital de la Misericordia from 2011 through 2013. Methodology: case study and controls. The medical records of patients with community methicillin resistant Staphylococcus aureus infection and control patients with community methicillin sensitive Staphylococcus aureus infection at the Hospital de la Misericordia between 2011 and 2013 were revised. The frequency of presentation of risk factors in each study group was determined and the OR was estimated. Results: 129 participants (73 males and 56 females), between 1-day-old and 17 year-old with at least one positive culture for community Staphylococcus aureus in sterile places. Age made no significant difference between the control group and the cases. Leukocytosis between 15.000 and 18.000 (OR= 3.1 (95% CI 1.1-8.9), p=0.02), neutrophils greater than 10000 cells/mm3 (OR= 3.4 (95% C.I. 1.58-7.46), p=0.002) and antibiotic use in the last three months (OR= 4.2 (IC95% 2.0-8.88) p=0.00), were the only statistically significant variables as risk factors for MRSA -CO. Conclusions: there are some risk factors for MRSA – CO infection among the pediatric population, including leukocytosis, neutrophilia and previous antibiotic use.

PDF (Español (España))

References

Jiménez JN, Correa MM. Staphylococcus aureus resistente a meticilina: bases moleculares de la resistencia, epidemiología y tipificación. Iatreia. 2009 Jun; 22(2): 147-158.

Leal A, Schmalbach J, Álvarez C, Buitrago G, Méndez M, Grebo. Canales Endémicos y Marcadores de Resistencia Bacteriana, en instituciones de Tercer Nivel de Bogotá, Colombia. Rev. salud pública. 2006 May; Sup. 8 (1): 59-70. https://doi.org/10.1590/S0124-00642006000400006

Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007; 298(15):1763-1771. https://doi.org/10.1001/jama.298.15.1763

Cortes A, Gómez CA, Cuervo SI, Leal AL. Implicaciones en Salud Pública de Staphylococcus aureus Meticilino Resistente Adquirido en la Comunidad en Bogotá, Colombia. Rev. salud pública [serial on the Internet]. 2007 Sep [cited 2014 July 30]; 9(3): 448-454. Available from: http://www. scielosp.org/scielo.php?script=sci_arttext&pid=S0124-00642007000300013&lng=en. https://doi.org/10.1590/S0124-00642007000300013

Sande-Bruinsma N, Grundmann H, Verloo D, Ferech M et al. European Surveillance of Antimicrobial Consumption Project Antimicrobial drug use and resistance in Europe. Emerg Infect. 2008 Nov; 14 (11): 1722-1730. https://doi.org/10.3201/eid1411.070467

Gorwittz RJ. A Review of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections. Pediatr Infect Dis J 2008; 27: 1-7. https://doi.org/10.1097/INF.0b013e31815819bb

Wen-Tsung Lo. Risk Factors and Molecular Analysis of Panton-Valentine Leukocidin-Positive Methicillin-Resistant Staphylcoccus aureus Colonization in Healthy Children. Pediatr Infect Dis J. 2008; 27: 713-718. https://doi.org/10.1097/INF.0b013e31816f63b5

Verdier I, Durand G, Bes M et al. Identification of the Capsular Polysaccharides in Staphylococcus aureus Clinical Isolates by PCR and Agglutination Tests.Clin. Microbiol. 2007 March; 45 (3); 725-729. https://doi.org/10.1128/JCM.01572-06

Ochoa V, Guzman A, Caicedo Y. Infección por estafilococo aureus meticilino resistente adquirido. Gastrohnup. 2007 Jul; 14 (2); S46-S57.

Leal Al, Álvarez Ca, Cortes Ja, Ovalle Mb, et al. Resultados de la vigilancia de la resistencia bacteriana año 2012 componente pediátrico y adulto. Boletín informativo GREBO. 2013; No 5: 15-17.

Leal Al, Álvarez Ca, Cortes Ja, Ovalle Mb, et al. Resultados de la vigilancia de la resistencia bacteriana año 2013 componente pediátrico y adulto. Boletín informativo GREBO. 2014; No 6: 15-17.

Pichereau S, Rose We. Invasive community - associated MRSA infections: epidemiology and antimicrobial management. Expert Opin. Pharmacother. 2010; 11 (18): 3009- 3025. https://doi.org/10.1517/14656566.2010.511614

Salgado Cd, Farr Bm, Calfee Dp. Community - Acquired Methicillin - Resistant Staphyloccus aureus: A Meta - Analysis of Prevalence and Risk Factors. Clin Infect Dis. 2003; 36:131-139. https://doi.org/10.1086/345436

Cantón J, Cobo L. Consumo de antimicrobianos y resistencia en el hospital: una relación difícil de medir y compleja de interpretar. Enferm Infecc Microbiol Clin. 2009; 27(8):437-440. https://doi.org/10.1016/j.eimc.2009.04.004

Aristizabal J, Robledo C. Estudio descriptivo de infecciones Stafilococo Aureus Meticilino Resistente-Adquirido en comunidad (SAMR-AC) en un centro hospitalario de Cali-Colombia. [Tesis doctoral]. Cali: Universidad CES. Facultad de Medicina, 2010.

Salgado F, Arroyo A, Lozano B et al. Infecciones de partes blandas. Med Clin (Barc). 2009;133(14):552-564. https://doi.org/10.1016/j.medcli.2008.11.021

Kevin B. Laupland,Terry Ross, and Daniel B. Gregson. Staphylococcus aureus Bloodstream Infections: Risk Factors, Outcomes, and the Influence of Methicillin Resistance in Calgary, Canada, 2000-2006. The Journal of Infectious Diseases 2008; 198:336-43. https://doi.org/10.1086/589717

Maree, Eells, Tan, Bancroft. Risk Factors for Infection and Colonization with Community-Associated Methicillin-Resistant Staphylococcus aureus in the Los Angeles County Jail: A Case-Control Study. Clinical Infectious Diseases 2010; 51(11):1248-1257. https://doi.org/10.1086/657067

Muttaiyah S, Coombs G, Pandey S, et al. Incidence, Risk Factors, and Outcomes of Panton-Valentine Leukocidin-Positive Methicillin-Susceptible Staphylococcus aureus Infections in Auckland, New Zealand. J. Clin. Microbiol. 2010 Oct; 48(10): 3470 - 3474. https://doi.org/10.1128/JCM.00911-10

Fritz, et al. Prevalence of and Risk Factors for Community-Acquired Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Colonization in Children Seen in a Practice-Based Research Network. Pediatrics June 2008; 121:6 1090-1098. https://doi.org/10.1542/peds.2007-2104

Wang J, Chun-Hsing Liao, Chi-Tai Fang, et al. Prevalence of and Risk Factors for Colonization by Methicillin-Resistant Staphylococcus aureus among Adults in Community Settings in Taiwan. J. Clin. Microbiol. 2009 Jul; 47(9): 2957 - 2963. https://doi.org/10.1128/JCM.00853-09

Adler A, Givon-Lavi N, Moses A, et al. Carriage of Community-Associated Methicillin-Resistant Staphylococcus aureus in a Cohort of Infants in Southern Israel: Risk Factors and Molecular Features. J. Clin. Microbiol; 2010 Feb; 48 (2): 531-538. https://doi.org/10.1128/JCM.02290-08

Frick, Moraga, Larrosa, et al. Infecciones por Staphylococcus aureus resistente a meticilina adquirido en la comunidad en niños. Enferm Infecc Microbiol Clin. 2010; 28(10): 675-679. https://doi.org/10.1016/j.eimc.2010.01.007

Castro, Villafane, Álvarez, et al. Staphylococcus aureus meticilino resistente en niños escolares de Cartagena. Rev. Salud pública. 2010 Jun; 12 (3): 454-463." https://doi.org/10.1590/S0124-00642010000300011

Downloads

Download data is not yet available.